.jpg)
Nasdaq (Nasdaq:NDAQ) announces today the updated results of the semi-annual review of the First North 25 Index (Nasdaq Stockholm: FN25) which will become effective with the market open on Thursday, January 2, 2020.
Absolent Group AB (ABSO), Akelius Residential Property AB ser. D (AKEL D), Genovis AB (GENO), Mentice AB (MNTC), Sdiptech AB ser. B (SDIP B), Surgical Science Sweden AB (SUS), Fastighets AB Trianon ser. B (TRIAN B) and Vostok Emerging Finance Ltd (VEMF SDB) will be added to the Index.
Aspire Global plc (ASPIRE), BIMobject AB (BIM), CELLINK AB ser. B (CLNK B), IRLAB Therapeutics AB ser. A (IRLAB A) and Verkkokauppa.com Oyj (VERK) will be removed from the Index.
The FN25 consists of the largest and most traded shares listed on the Nasdaq First North Growth Market. Companies included in the FN25 are selected through a two-step process as follows:
- The 30 largest companies measured by market capitalization are selected.
- The 25 most traded shares within this pool, measured by aggregated trading turnover over a six month period, are selected for the index.
FN25 is reviewed semi-annually in January and July.
The First North 25 Index constituents effective January 2, 2020 are:
| Embracer Group AB ser. B | Sedana Medical AB |
| PowerCell Sweden AB | Smart Eye AB |
| Stillfront Group AB | Sdiptech AB ser. B |
| Kambi Group Plc | Amasten Fastighets AB |
| SpectraCure AB | Mentice AB |
| Maha Energy AB | Admicom Oyj |
| Cibus Nordic Real Estate AB | Fastighets AB Trianon ser. B |
| Paradox Interactive AB | Ovzon AB |
| Climeon AB ser. B | Surgical Science Sweden AB |
| Minesto AB | Detection Technology Oyj |
| Akelius Residential Property AB ser. D | Vostok Emerging Finance Ltd |
| Storytel AB ser. B | Absolent Group AB |
| Genovis AB | |
